Kristofer Svensson

Director Financiero/CFO en GABATHER AB .

Health Technology

Consumer Services

Electronic Technology

Perfil

Kristofer Svensson currently works at Gabather AB, as Chief Financial Officer, Bioextrax AB, as Chief Financial Officer from 2023, Sinfonia Biotherapeutics AB, as Chief Financial Officer from 2022, Ectin Research AB, as Chief Financial Officer, and Melius Pharma AB, as Chief Financial Officer from 2022.
Mr. Svensson also formerly worked at Sensidose AB, as Chief Financial Officer from 2017 to 2022.
Mr. Svensson received his graduate degree from the University of Stockholm.

Cargos activos de Kristofer Svensson

Empresas	Cargo	Inicio
GABATHER AB	Director Financiero/CFO	-
BIOEXTRAX AB	Director Financiero/CFO	01/01/2023
ECTIN RESEARCH AB	Director Financiero/CFO	-
Melius Pharma AB Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients.	Director Financiero/CFO	01/05/2022
Sinfonia Biotherapeutics AB Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a clinical stage company based in Huddinge, Sweden. The Swedish company develops biologics for the treatment of neuropathic pain.	Director Financiero/CFO	01/01/2022

Todos los cargos activos de Kristofer Svensson

Antiguos cargos conocidos de Kristofer Svensson.

Empresas	Cargo	Fin
SENSIDOSE AB	Director Financiero/CFO	01/10/2022

Ver el detalle de la experiencia de Kristofer Svensson.

Formación de Kristofer Svensson.

University of Stockholm

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kristofer Svensson.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	4
GABATHER AB	Health Technology
BIOEXTRAX AB	Health Technology
SENSIDOSE AB	Electronic Technology
ECTIN RESEARCH AB	Health Technology

Empresas privadas	2
Melius Pharma AB Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients.	Health Technology
Sinfonia Biotherapeutics AB Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a clinical stage company based in Huddinge, Sweden. The Swedish company develops biologics for the treatment of neuropathic pain.	Health Technology